Assignee
SYNLOGIC OPERATING CO INC
22 granted patents·32 pending applications·71 citations·filing 2016–2024
Top patents by PatentIndex Score
54 records- 0196US10273489B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 30, 2019·12 cites·6 claims
- 0294US11291693B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 5, 2022·9 cites·19 claims
- 0394US10933102B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2017·Granted Mar 2, 2021·7 cites·22 claims
- 0494US10610546B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 7, 2020·7 cites·8 claims
- 0593US11471494B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Granted Oct 18, 2022·7 cites·10 claims
- 0692US11060073B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2017·Granted Jul 13, 2021·5 cites·38 claims
- 0791US11723932B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2017·Granted Aug 15, 2023·5 cites·7 claims
- 0890US11766463B2Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2022·Granted Sep 26, 2023·3 cites·8 claims
- 0990US11618894B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 4, 2023·5 cites·33 claims
- 1089US10195234B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Feb 5, 2019·6 cites·15 claims
- 1188US12171790B2Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2023·Granted Dec 24, 2024·1 cites·29 claims
- 1285US11879123B2Bacteria for the treatment of disordersSYNLOGIC OPERATING CO INC·Filed 2018·Granted Jan 23, 2024·4 cites·24 claims
- 1376US12545886B2Bacteria for the treatment of disordersSYNLOGIC OPERATING CO INC·Filed 2023·Granted Feb 10, 2026·0 cites·20 claims
- 1475US2025295707A1Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2024·Application pending·0 cites
- 1574US2024382536A1Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1673US11845964B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2020·Granted Dec 19, 2023·0 cites·20 claims
- 1773US2024076645A1Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 1872US12409195B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2020·Granted Sep 9, 2025·0 cites·9 claims
- 1972US2021095297A1Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal BarrierSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 2071US11896627B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2022·Granted Feb 13, 2024·0 cites·22 claims
- 2169US2023226122A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2267US11859189B2Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2022·Granted Jan 2, 2024·0 cites·14 claims
- 2367US2024110192A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2466US11883439B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2020·Granted Jan 30, 2024·0 cites·17 claims
- 2566US2024102024A1Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2665US11384359B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jul 12, 2022·0 cites·18 claims
- 2764US2024180974A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2862US2022233609A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2961US2024110191A1Engineered microorganismsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3060US2023174926A1Bacteria engineered to treat disorders involving the catabolism of leucineSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3159US2023332164A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3258US2023293603A1Recombinant bacteria for production of d-lactate and/or l-lactate and uses thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3357US2024191176A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3457US2021369836A1Surface display of proteins on recombinant bacteria and uses thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3556US2024197843A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3656US2022257732A1Enumeration of genetically engineered microorganisms by live cell counting techniquesSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 3756US2022168362A1Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acidSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3856US2023043588A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3955US2023183295A1Recombinant bacteria for use as a vaccine to prevent covid19 infectionSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4054US11685925B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jun 27, 2023·0 cites·17 claims
- 4154US2024316122A1Methods of treating cancer using recombinant microorganisms expressing a sting agonistSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 4253US2021130806A1Engineered bacteria expressing racemase for treating diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2018·Application pending·0 cites
- 4353US2024316121A1Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4451US11273184B2Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2016·Granted Mar 15, 2022·0 cites·20 claims
- 4551US2022362311A1Optimized bacteria engineered to treat disorders involving the catabolism of leucine, isoleucine, and/or valineSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 4651US2023092431A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4748US2023172997A1Recombinant bacteria for production of indole-3-acetic acid (iaa) and uses thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4846US11439673B2Bacteria engineered to treat liver diseaseSYNLOGIC OPERATING CO INC·Filed 2019·Granted Sep 13, 2022·0 cites·22 claims
- 4946US2023105474A1Recombinant bacteria engineered to treat diseases associated with uric acid and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 5045US2020149053A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →